Shannon E. Dunn
University of Toronto · 73 works · 4,398 citations · h-index 28
Top works
- Calcineurin Is Required for Skeletal Muscle Hypertrophy
- Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
- PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
- Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology
- Matching of Calcineurin Activity to Upstream Effectors Is Critical for Skeletal Muscle Fiber Growth
- Regulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents
- Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity
- Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way
- Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
- Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
- Calcineurin and skeletal muscle growth
- Coordinated expression of myosin heavy chain isoforms and metabolic enzymes within overloaded rat muscle fibers
- Mechanisms and consequences of sex differences in immune responses
- Nerve Activity-dependent Modulation of Calcineurin Signaling in Adult Fast and Slow Skeletal Muscle Fibers
- Sex-Specific T-Cell Regulation of Angiotensin II–Dependent Hypertension
- Regulation of myosin heavy chain expression in adult rat hindlimb muscles during short‐term paralysis: comparison of denervation and tetrodotoxin‐induced neural inactivation
- Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females
- Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunity
- Statins in the treatment of central nervous system autoimmune disease
- Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice